Alerts will be sent to your verified email
Verify EmailLINCOLN
Lincoln Pharma
|
Bliss GVS Pharma
|
Shivalik Rasayan
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
8.98 % | n/a | n/a |
R&D as a % of Total Sales
|
1.93 % | 2.57 % | n/a |
Financials
|
|||
5 yr Average ROE
|
15.94 % | 7.87 % | 7.33 % |
5yr average Equity Multiplier
|
1.3 | 1.33 | 1.84 |
5yr Average Asset Turnover Ratio
|
0.84 | 0.63 | 0.47 |
5yr Avg Net Profit Margin
|
14.61 % | 9.44 % | 8.37 % |
Price to Book
|
1.83 | 1.28 | 1.78 |
P/E
|
13.07 | 21.68 | 55.72 |
5yr Avg Cash Conversion Cycle
|
24.49 Days | 169.17 Days | 79.22 Days |
Inventory Days
|
42.89 Days | 51.37 Days | 63.09 Days |
Days Receivable
|
90.22 Days | 187.07 Days | 114.67 Days |
Days Payable
|
111.35 Days | 75.42 Days | 157.87 Days |
5yr Average Interest Coverage Ratio
|
58.2 | 15.0 | 10.93 |
5yr Avg ROCE
|
20.48 % | 14.67 % | 9.58 % |
5yr Avg Operating Profit Margin
|
18.48 % | 17.43 % | 18.09 % |
5 yr average Debt to Equity
|
0.0 | 0.13 | 0.16 |
5yr CAGR Net Profit
|
12.65 % | -4.95 % | -1.91 % |
5yr Average Return on Assets
|
12.28 % | 5.91 % | 3.97 % |
Shareholdings
|
|||
Promoter Holding
|
49.78 % | 35.29 % | 47.37 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
7.73 % | 2.15 % | -2.95 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Lincoln Pharma
|
Bliss GVS Pharma
|
Shivalik Rasayan
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|